{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:29:24Z","timestamp":1746786564591,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00347-021-01359-8","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T09:08:53Z","timestamp":1615885733000},"page":"388-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Follikul\u00e4res Lymphom der Bindehaut mit aggressiv transformiertem systemischem Befall","Follicular conjunctival lymphoma with aggressively transformed systemic involvement"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-1460","authenticated-orcid":false,"given":"V.","family":"Sch\u00f6neberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. I.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lohneis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"issue":"5","key":"1359_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.survophthal.2015.05.001","volume":"60","author":"MM Kirkegaard","year":"2015","unstructured":"Kirkegaard\u00a0MM et\u00a0al (2015) Malignant lymphoma of the conjunctiva. Surv Ophthalmol 60(5):444\u2013458","journal-title":"Surv Ophthalmol"},{"key":"1359_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40662-019-0146-1","volume":"6","author":"RE Tanenbaum","year":"2019","unstructured":"Tanenbaum\u00a0RE et\u00a0al (2019) Classification, diagnosis, and management of conjunctival lymphoma. Eye Vis (Lond) 6:22","journal-title":"Eye Vis (Lond)"},{"issue":"6","key":"1359_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00347-019-01020-5","volume":"117","author":"V Kakkassery","year":"2020","unstructured":"Kakkassery\u00a0V et\u00a0al (2020) Ocular lymphoma: precise diagnostics and classification as key for successful personalized treatment. Ophthalmologe 117(6):499\u2013507","journal-title":"Ophthalmologe"},{"issue":"3","key":"1359_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00347-014-3205-y","volume":"112","author":"V Kakkassery","year":"2015","unstructured":"Kakkassery\u00a0V et\u00a0al (2015) Lymphoma of the ocular adnexa. Ophthalmologe 112(3):210\u2013216","journal-title":"Ophthalmologe"},{"issue":"1","key":"1359_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans\u00a0CP et al (2004) Confirmation of the molecular classification of diffuse large B\u2011cell lymphoma by immunohistochemistry using a\u00a0tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"1","key":"1359_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1182\/asheducation-2005.1.314","volume":"2005","author":"AS Freedman","year":"2005","unstructured":"Freedman\u00a0AS (2005) Biology and management of histologic transformation of indolent lymphoma. Hematology Am Soc Hematol Educ Program 2005(1):314\u2013320","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"20","key":"1359_CR7","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow\u00a0SH et\u00a0al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"4","key":"1359_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion\u00a0Y et\u00a0al (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J\u00a0Clin Oncol 15(4):1587\u20131594","journal-title":"J Clin Oncol"},{"issue":"7","key":"1359_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaophthalmol.2014.376","volume":"132","author":"PK Rasmussen","year":"2014","unstructured":"Rasmussen\u00a0PK et\u00a0al (2014) Ocular adnexal follicular lymphoma: a\u00a0multicenter international study. JAMA Ophthalmol 132(7):851\u2013858","journal-title":"JAMA Ophthalmol"},{"issue":"18","key":"1359_CR10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","volume":"126","author":"R Kridel","year":"2015","unstructured":"Kridel\u00a0R et\u00a0al (2015) Cell of origin of transformed follicular lymphoma. Blood 126(18):2118\u20132127","journal-title":"Blood"},{"issue":"25","key":"1359_CR11","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/sj.onc.1210378","volume":"26","author":"AJ Davies","year":"2007","unstructured":"Davies\u00a0AJ (2007) Radioimmunotherapy for B\u2011cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab. Oncogene 26(25):3614\u20133628","journal-title":"Oncogene"},{"issue":"13","key":"1359_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1182\/blood.2018891598","volume":"134","author":"A Goy","year":"2019","unstructured":"Goy\u00a0A et al (2019) Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed\/refractory non-germinal center B\u2011cell-like DLBCL. Blood 134(13):1024\u20131036","journal-title":"Blood"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01359-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:07:09Z","timestamp":1649754429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01359-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"type":"print","value":"0941-293X"},{"type":"electronic","value":"1433-0423"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0Sch\u00f6neberger, F.I.\u00a0Meyer, P.\u00a0Lohneis und L.M.\u00a0Heindl geben an, dass kein Interessenkonflikt besteht.>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}